Evidence map›Paper›PMID 38438733›Full record

ReviewMolecular systems biology2024

Unique transcriptomes of sensory and non-sensory neurons: insights from Splicing Regulatory States.

Ludovica Ciampi, Luis Serrano, Manuel Irimia

Abstract readReview
In one paragraph

Review in Molecular systems biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ludovica CiampiCenter for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. ludovica.ciampi@crg.eu.ORCID http://orcid.org/0000-0002-3309-2402
Luis SerranoCenter for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. luis.serrano@crg.eu.ORCID http://orcid.org/0000-0002-5276-1392
Manuel IrimiaCenter for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain. mirimia@gmail.com.ORCID http://orcid.org/0000-0002-2179-2567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alternative Splicing (AS) programs serve as instructive signals of cell type specificity, particularly within the brain, which comprises dozens of molecularly and functionally distinct cell types. Among them, retinal photoreceptors stand out due to their unique transcriptome, making them a particularly well-suited system for studying how AS shapes cell type-specific molecular functions. Here, we use the Splicing Regulatory State (SRS) as a novel framework to discuss the splicing factors governing the unique AS pattern of photoreceptors, and how this pattern may aid in the specification of their highly specialized sensory cilia. In addition, we discuss how other sensory cells with ciliated structures, for which data is much scarcer, also rely on specific SRSs to implement a proteome specialized in the detection of sensory stimuli. By reviewing the general rules of cell type- and tissue-specific AS programs, firstly in the brain and subsequently in specialized sensory neurons, we propose a novel paradigm on how SRSs are established and how they can diversify. Finally, we illustrate how SRSs shape the outcome of mutations in splicing factors to produce cell type-specific phenotypes that can lead to various human diseases.

Indexed as

Sensory Receptor CellsTranscriptomeAlternative SplicingHumansPhotoreceptor CellsRNA Splicing FactorsRNA Splicing FactorsAlternative SplicingCell TypesPhotoreceptorsRegulatory StatesSensory Neurons

Identifiers

PMID38438733
PMCPMC10987577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.